Yohimbinos 2.5mg Research Overview
Yohimbinos 2.5mg by Driada Medical is an alpha-2 adrenergic antagonist compound derived from the bark of the Pausinystalia yohimbe tree, widely studied for its metabolic research applications. This research chemical is manufactured to pharmaceutical standards and supplied exclusively for in-vitro laboratory investigations. Researchers at Stroid UK Shop frequently examine yohimbine hydrochloride for its unique receptor binding properties and potential interactions with adrenergic signalling pathways. The compound’s molecular structure allows investigators to study alpha-2 adrenoreceptor antagonism in controlled laboratory environments, making it valuable for metabolic research protocols.
Scientific Research Applications
Laboratory studies focus on yohimbine’s capacity to block alpha-2 adrenergic receptors, which researchers examine in relation to lipolytic mechanisms and sympathetic nervous system modulation. In controlled experimental settings, scientists investigate how this compound influences norepinephrine release and subsequent downstream signalling cascades. Research teams studying metabolic modulators often incorporate yohimbine into comparative analyses with other adrenergic compounds. The pharmaceutical-grade formulation enables precise dosometric research protocols, while investigators examine dose-response relationships in cellular models. Scientists also evaluate the compound’s potential synergistic effects when studied alongside other research chemicals from categories including selective androgen receptor modulators and research peptides in comprehensive metabolic pathway investigations.
Technical Specifications
| Active Compound | Yohimbine Hydrochloride |
|---|---|
| Concentration | 2.5mg per tablet |
| Manufacturer | Driada Medical |
| Purity Level | Verify with supplier |
| CAS Number | 65-19-0 |
| Molecular Formula | C₂₁H₂₆N₂O₃·HCl |
| Storage Requirements | Cool, dry conditions |
| Research Classification | Alpha-2 adrenergic antagonist |
Laboratory Compliance Requirements
This product is manufactured exclusively for in-vitro research purposes and laboratory investigations. Yohimbinos 2.5mg is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with institutional research protocols and safety guidelines when handling this compound. All studies should be conducted by qualified personnel in appropriately equipped laboratory facilities with proper safety measures in place.
